• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. BIOLOX DELTA HIP; HEAD, FEMORAL, CERAMIC, BILOX DELTA, 32MM NEUTRAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. BIOLOX DELTA HIP; HEAD, FEMORAL, CERAMIC, BILOX DELTA, 32MM NEUTRAL Back to Search Results
Model Number 400-03-322
Health Effect - Clinical Code Joint Dislocation (2374)
Date of Event 03/21/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional reporting on this event will be provided as a supplemental report to these documents as soon as it becomes available.
 
Event or Problem Description
Revision surgery - the patient dislocated.She was in need of a constrained liner.
 
Additional Manufacturer Narrative
Manufacturer narrative: the reason for this revision surgery was due to dislocation.The previous surgery and the surgery detailed in this event occurred 53 days apart.There was no information submitted with this complaint about any patient activities, accidents, or medical contraindications that may have contributed to the reported event.The healthcare professional indicated there was no delay in surgery and another suitable device was available.The revision surgery was completed as intended and without incident.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the device history record show that the reported component used in the previous surgery, when released for use, met design and manufacturing requirements.There were no nonconforming material reports associated with the product that may have contributed to the reported event.The device was verified to have gone through an acceptable sterilization process and was within its expiration date at the time of the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are needing a review.The root cause of this complaint was a revision surgery due to dislocation.There were no findings during this evaluation that indicate that the reported device was defective.There are multiple factors that may contribute to an event that are outside of the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOLOX DELTA HIP
Common Device Name
HEAD, FEMORAL, CERAMIC, BILOX DELTA, 32MM NEUTRAL
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin, tx 78758-5445,
MDR Report Key9973165
Report Number1644408-2020-00341
Device Sequence Number13619536
Product Code LZO
UDI-Device Identifier00888912076098
UDI-Public(01)00888912076098
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K082844
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/04/2024
Device Model Number400-03-322
Device Catalogue Number400-03-322
Device Lot Number861B1182
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/21/2020
Supplement Date Received by Manufacturer04/17/2020
04/17/2020
Initial Report FDA Received Date04/17/2020
Supplement Report FDA Received Date05/14/2020
05/22/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
931-32-750 LOT 759N2018
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age53 YR
Patient Weight59
-
-